The Revised “Points to Consider” Document

Abstract

Human Gene TherapyVol. 1, No. 1 News and CommentsThe Revised “Points to Consider” DocumentPublished Online:12 Jun 2008https://doi.org/10.1089/hum.1990.1.1-93AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byEmerging treatment for congenital adrenal hyperplasiaCurrent Opinion in Endocrinology, Diabetes & Obesity, Vol. 29, No. 3Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future LeRoy Walters, Robert M. Cook-Deegan, and Eli Y. Adashi16 August 2021 | The CRISPR Journal, Vol. 4, No. 4Pathways toward the future: points to consider for oncofertility oversight11 December 2012 | Journal of Cancer Survivorship, Vol. 7, No. 1FDA comments on phase I clinical trials without vector biodistribution dataNature Genetics, Vol. 22, No. 4The Application of Genetic Knowledge: Ethical and Policy ImplicationsAACN Clinical Issues: Advanced Practice in Acute and Critical Care, Vol. 9, No. 4Aspekte der somatischen Gentherapie in der Herz- und KreislaufmedizinGene therapy: regulatory issues and international approaches to regulationCurrent Opinion in Biotechnology, Vol. 8, No. 3The Ethics of Somatic and Germline Gene TherapyAnnals of the New York Academy of Sciences, Vol. 816, No. 1 Adolescent GySafety and regulation at the leading edge of biomedical biotechnologyCurrent Opinion in Biotechnology, Vol. 7, No. 3Gene therapy for head and neck cancerHead & Neck, Vol. 17, No. 6Ethical and regulatory issues in gene therapyBritish Journal of Urology, Vol. 76Guidance on Making Proposals to Conduct Gene Therapy Research on Human Subjects Report of the United Kingdom Health Ministers' Gene Therapy Advisory Committee19 March 2008 | Human Gene Therapy, Vol. 6, No. 3Human cancer and gene therapyAnnals of Hematology, Vol. 69, No. 6Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy Hitoshi Kotani, Perry B. Newton, Shuyuan Zhang, Yawen L. Chiang, Edward Otto, Linda Weaver, R. Michael Blaese, W. French Anderson, and Gerard J. McGarrity19 March 2008 | Human Gene Therapy, Vol. 5, No. 1Hepatic gene therapy: Present and futureHepatology, Vol. 18, No. 5Gene Therapy of Cancer11 June 2009 | Cancer Investigation, Vol. 11, No. 6Human gene therapy comes of ageNature, Vol. 357, No. 6378Introduction and Abstracts from Journal of Medicine and Philosophy Thematic Issue on Germ-Line Gene Therapy Eric T. Juengst13 June 2008 | Human Gene Therapy, Vol. 3, No. 1The NIH “Points to Consider” and the Limits of Human Gene Therapy Eric T. Juengst12 June 2008 | Human Gene Therapy, Vol. 1, No. 4 Volume 1Issue 1Apr 1990 InformationCopyright 1990, Mary Ann Liebert, Inc.To cite this article:The Revised “Points to Consider” Document.Human Gene Therapy.Apr 1990.93-103.http://doi.org/10.1089/hum.1990.1.1-93Published in Volume: 1 Issue 1: June 12, 2008PDF download